These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


541 related items for PubMed ID: 25305334

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS, Sinha BN, Hilgenfeld R, Jayaprakash V.
    Curr Comput Aided Drug Des; 2017 Nov 10; 13(4):346-361. PubMed ID: 28294048
    [Abstract] [Full Text] [Related]

  • 26. Suppression of the Arboviruses Dengue and Chikungunya Using a Dual-Acting Group-I Intron Coupled with Conditional Expression of the Bax C-Terminal Domain.
    Carter JR, Taylor S, Fraser TS, Kucharski CA, Dawson JL, Fraser MJ.
    PLoS One; 2015 Nov 10; 10(11):e0139899. PubMed ID: 26580561
    [Abstract] [Full Text] [Related]

  • 27. Chikungunya nsP4 homology modeling reveals a common motif with Zika and Dengue RNA polymerases as a potential therapeutic target.
    Reyes-Gastellou A, Jiménez-Alberto A, Castelán-Vega JA, Aparicio-Ozores G, Ribas-Aparicio RM.
    J Mol Model; 2021 Aug 13; 27(9):247. PubMed ID: 34386905
    [Abstract] [Full Text] [Related]

  • 28. [Ocular manifestations of emerging arboviruses: Dengue fever, Chikungunya, Zika virus, West Nile virus, and yellow fever (French translation of the article)].
    Merle H, Donnio A, Jean-Charles A, Guyomarch J, Hage R, Najioullah F, Césaire R, Cabié A.
    J Fr Ophtalmol; 2018 Sep 13; 41(7):659-668. PubMed ID: 30173871
    [Abstract] [Full Text] [Related]

  • 29. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG.
    Antiviral Res; 2008 Nov 13; 80(2):94-101. PubMed ID: 18674567
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY, Silengo SJ, Whiteman MC, Kinney RM.
    J Virol; 2005 Jun 13; 79(12):7300-10. PubMed ID: 15919884
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Chikungunya virus infections: time to act, time to treat.
    Abdelnabi R, Neyts J, Delang L.
    Curr Opin Virol; 2017 Jun 13; 24():25-30. PubMed ID: 28414993
    [Abstract] [Full Text] [Related]

  • 35. Insight the data: Wikipedia's researches and real cases of arboviruses in Italy.
    Provenzano S, Gianfredi V, Santangelo OE.
    Public Health; 2021 Mar 13; 192():21-29. PubMed ID: 33607517
    [Abstract] [Full Text] [Related]

  • 36. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
    Pryke KM, Abraham J, Sali TM, Gall BJ, Archer I, Liu A, Bambina S, Baird J, Gough M, Chakhtoura M, Haddad EK, Kirby IT, Nilsen A, Streblow DN, Hirsch AJ, Smith JL, DeFilippis VR.
    mBio; 2017 May 02; 8(3):. PubMed ID: 28465426
    [Abstract] [Full Text] [Related]

  • 37. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K, Sallamand C, Petzold C, Coutard B, Collet A, Thillier Y, Zimmermann J, Vasseur JJ, Canard B, Rohayem J, Debart F, Decroly E.
    Antiviral Res; 2013 Sep 02; 99(3):292-300. PubMed ID: 23769894
    [Abstract] [Full Text] [Related]

  • 38. Seroprevalence of yellow fever, dengue, West Nile and chikungunya viruses in children in Teso South Sub-County, Western Kenya.
    Inziani M, Adungo F, Awando J, Kihoro R, Inoue S, Morita K, Obimbo E, Onyango F, Mwau M.
    Int J Infect Dis; 2020 Feb 02; 91():104-110. PubMed ID: 31712089
    [Abstract] [Full Text] [Related]

  • 39. Viral Exploration of Negative Acute Febrile Cases Observed during Chikungunya Outbreaks in Gabon.
    Simo Tchetgna H, Sem Ouilibona R, Nkili-Meyong AA, Caron M, Labouba I, Selekon B, Njouom R, Leroy EM, Nakoune E, Berthet N.
    Intervirology; 2018 Feb 02; 61(4):174-184. PubMed ID: 30625488
    [Abstract] [Full Text] [Related]

  • 40. The dengue virus non-structural 1 protein: risks and benefits.
    Amorim JH, Alves RP, Boscardin SB, Ferreira LC.
    Virus Res; 2014 Mar 06; 181():53-60. PubMed ID: 24434336
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.